Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Deluxe
DLX
$1.1B
| $9.58M | 0.01% |
132,800
+103,600
| +355% | +$7.59M |
|
|
FIT
1277
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $9.56M | 0.01% |
1,614,994
+255,394
| +19% | +$1.62M |
|
|
RYZ
1278
Ryerson Holding Corp
RYZ
$1.49B
| $9.56M | 0.01% |
758,500
-151,900
| -17% | -$1.73M |
|
1279
SouthState Bank Corp
SSB
$10.8B
| $9.56M | 0.01% |
106,950
-102,533
| -49% | -$9.05M |
|
|
EARN
1280
Ellington Residential Mortgage REIT
EARN
$166M
| $9.55M | 0.01% |
651,600
+4,074
| +0.6% | +$56.4K |
|
|
ACC
1281
DELISTED
American Campus Communities, Inc.
ACC
| $9.55M | 0.01% |
200,700
-103,900
| -34% | -$5.07M |
|
1282
Clean Energy Fuels
CLNE
$392M
| $9.49M | 0.01% |
3,722,278
-849,100
| -19% | -$2.24M |
|
|
ALE
1283
DELISTED
Allete
ALE
| $9.49M | 0.01% |
140,100
+30,800
| +28% | +$2.02M |
|
1284
Ezcorp Inc
EZPW
$1.8B
| $9.45M | 0.01% |
1,159,718
+106,800
| +10% | +$979K |
|
1285
MasterCraft Boat Holdings
MCFT
$600M
| $9.43M | 0.01% |
583,000
-74,400
| -11% | -$1.11M |
|
1286
3M
MMM
$93.5B
| $9.42M | 0.01% |
+58,896
| New | +$9.03M |
|
|
UMPQ
1287
DELISTED
Umpqua Holdings Corp
UMPQ
| $9.4M | 0.01% |
530,178
+295,900
| +126% | +$5.44M |
|
|
EOCC
1288
DELISTED
Enel Generacion Chile S.A.
EOCC
| $9.38M | 0.01% |
421,600
-96,300
| -19% | -$1.97M |
|
|
PMD
1289
DELISTED
Psychemedics Corporation
PMD
| $9.37M | 0.01% |
467,400
-32,590
| -7% | -$715K |
|
1290
Shutterstock
SSTK
$205M
| $9.36M | 0.01% |
226,300
-83,900
| -27% | -$4M |
|
|
GCI
1291
DELISTED
Gannett Co., Inc
GCI
| $9.33M | 0.01% |
+1,113,400
| New | +$9.95M |
|
|
ACTA
1292
DELISTED
Actua Corp
ACTA
| $9.33M | 0.01% |
663,919
+1,800
| +0.3% | +$25.2K |
|
|
EMKR
1293
DELISTED
Emcore Corp
EMKR
| $9.31M | 0.01% |
103,432
-25,678
| -20% | -$2.34M |
|
|
ESGR
1294
DELISTED
Enstar Group
ESGR
| $9.3M | 0.01% |
48,600
-6,200
| -11% | -$1.2M |
|
|
MNDT
1295
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $9.27M | 0.01% |
734,900
+447,600
| +156% | +$5.34M |
|
|
MYCC
1296
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $9.25M | 0.01% |
576,100
+371,652
| +182% | +$6.1M |
|
1297
Artesian Resources
ARTNA
$368M
| $9.21M | 0.01% |
282,700
+17,400
| +7% | +$554K |
|
1298
Melco Resorts & Entertainment
MLCO
$2.14B
| $9.18M | 0.01% |
+495,137
| New | +$8.49M |
|
1299
Interparfums
IPAR
$3.75B
| $9.16M | 0.01% |
250,613
+25,523
| +11% | +$884K |
|
1300
Powell Industries
POWL
$7.6B
| $9.14M | 0.01% |
795,900
+72,600
| +10% | +$864K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.